Progress on cassaine-type diterpenoid ester amines and amides (Erythrophleum Alkaloids)

Natural Product Communications

Volumn 1, Issue 10, 2006, Pages 839-850

  Qu, Jing ^a   Yu, Shishan ^a   Tang, Wenzhao ^a   Liu, Yunbao ^a   Liu, Yue ^a   Liu, Jing ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Bioactivities; Cassaine type diterpenoid ester amines and amides; Erythrophleum alkaloids; Spectral characteristics; Structural modification; Structures

Indexed keywords

EID: 34347272182     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0600101005     Document Type: Review

References (60)

1. Hauth VH. (1974) Erythrophleum alkaloids. Planta Medica, 25, 201-215.
2. Ruzicka L, Plattner PA, Engel BG. (1944) Zur Kenntnis der Erythrophleum-alkaloide. 7. Mitteilung. Über β- dialkylaminoäthylester und β-dialkylamino-äthylamide einiger gallensäure. Helvetica Chimica Acta, 27, 1553-1560.
3. Cronlund A. (1973) New alkaloids from Erythrophleum species. Planta Medica, 24, 371-374.
4. Hauth H, Stauffacher D, Niklaus P, Melera A. (1965) Zur absoluten konfiguration von cassain. Helvetica Chimica Acta, 48, 1087-1093.
5. Clarke RL. (1971) Erythrophleum alkaloids. Phytochemistry, 10, 851-856.
6. The Merck Index, 9th Ed. (1976), p.1884.
7. Dalma G. (1939) Zur kenntnis der Erythrophleum-alkaloide. 1. Mitteilung. Cassain, ein krystallisiertes alkaloid aus der rinde von Erythrophleum guineense (G. Don). Helvetica Chimica Acta, 22, 1497-1512.
8. Tsutsui M, Tsutsup EA. (1959) Diterpenoids. Chemical Reviews, 59, 1031-1075.
9. Loder JW, Culvenor CCJ, Nearn RH, Russell GB, Stanton DW. (1974) Tumour inhibitory plants. New alkaloids from the bark of Erythrophleum chlorostachys (Leguminosae). Australian Journal of Chemistry, 27, 179-185.
10. Ruzicka L, Dalma G. (1940) Zur Kenntnis der Erythrophleum-alkaloide. 3. Mitteilung. Cassaidin, ein zweites krystallisiertes Alkaloid aus der rinde von Erythrophleum guineense (G. Don) und seine beziehung zum cassain. Helvetica Chimica Acta, 23, 753-764.
11. Robert LC, Sol JD, Philip ES, Rudolph KK. (1966) The structure of cassaic acid. Journal of the American Chemical Society, 88, 5865-5871.
12. Ruzicka L, Dalma G, Scott WE. (1941) Zur Kenntnis der Erythrophleum-alkaloide. 4. Mitteilung. Coumingin, ein krystallisiertes alkaloid aus der rinde von Erythrophleum couminga (H. Baillon) und seine beziehung zum cassain. Helvetica Chimica Acta, 24, 63-76.
13. Ruzicka L, Dalma G, Engel BG, Scott WE. (1941) Zur Kenntnis der Erythrophleum -alkaloide. 5. Mitteilung. Identifizierung der niedermolekularen spaltsäure des coumingins. Helvetica Chimica Acta, 24, 1449-1458.
14. Turner RB, Buchardt O, Herzog E, Morin RB, Riebel A, Sanders JM. (1966) The structure and total synthesis of cassaic acid. Journal of the American Chemical Society, 88, 1766-1775.
15. Thorell A, Agurell S, Sanberg F, Nortin T. (1968) Three new alkaloids from the bark of Erythrophleum guineense G. Don syn. E. suaveolens (Guill.& Perr) Brenan. Acta Chemica Scandinavica, 22, 2835-2844.
16. Ottinger R, Chiurdoglu G, Vandendris J. (1965) Determination of the structure of ivorine. Bulletin de la Societe Chimique Belges, 74, 198-199.
17. Manfouo RN, Lontsi D, Ngounou FN, Ngadjui BT, Sondengam BL. (2005) Erythrosuavine, a new diterpenic alkaloid from Erythrophleum suaveolens (Guill. & Perr.) Brenan. Bulletin of the Chemical Society of Ethiopia, 19, 69-74.
18. Engel BG. (1959) Zur Kenntnis der Erythrophleum-alkaloide. 15. Mitteilung. Überführung von cassaidin in cassain. Helvetica Chimica Acta, 42, 1127-1131.
19. Arya VP. (1962) The chemistry of natural products. II. Structure of erythrophleadienolic acid. Journal of Scientific.& Industrial. Research, 21B, 381-387.
20. Loder JW, Cluvenor CCJ, Nearn RH, Russell GB, Stanton DW. (1972) Isolation of norcassamidide and authentic norcassamidine from Erythrophleum chlorostachys. Structural revision of the alkaloids previously known as norcassamidine, norcassamine, norethythrosuamine and dehydro-norerythrosuamine. Tetrahedron Letters, 50, 5069-5072.
21. Fiechtl JF, SpitellerG. (1971) Anwendung der massenspektrometrie zur strukturaufklärung von alkaloiden, X. Neue alkaloide aus Erythrophleum guineense und über das muawin. Chemische Berichte, 104, 3535-3548.
22. Blount BK, Openshaw HT, Todd AR. (1940) The Erythrophleum alkaloids. Part I. Erythrophleine. Journal of the Chemical Society, 286-290.
23. Verotta L, Aburjai T, Rogers CB, Dorigo P, Maragno I, Fraccarollo D, Santostasi G, Gaion RM, Floreani M, Carpenedo F. (1995) Chemical and pharmacological characterization of Erythrophleum lasianthum alkaloids. Planta Medica, 61, 271-274.
24. Michael JF, Alan FF, John WL, Roland HN. (1975) Isolation of unstable alkaloids from Erythrophleum chlorostachys (Leguminosae). Australian Journal of Chemistry, 28, 645-650.
25. Sandberg F, Verpoorte R, Cronlund A. (1971) Screening of African Strychnos species for convulsant muscle-relaxant effects. Acta Pharmaceutica Suecica, 8, 341-350.
26. Qu J, Hu YC, Yu SS, Chen XG, Li Y. (2006) New cassaine diterpenoid amides with cytotoxic activities from the bark of Erythrophleum fordii. Planta Medica, 72, 442-449.
27. Sangster AW, Stuart KL. (1965) Ultraviolet spectra of alkaloids. Chemical Reviews, 65, 69-130.
28. Cronlund A, Sandberg F. (1976) Cardiotonic effect and toxicity of Erythrophleum alkaloids. Acta Pharmaceutica Suecica, 13, 35-42.
29. Cronlund A. (1976) Synthesis and cardiotonic activity of three new cassaine analogues. Acta Pharmaceutica Suecica, 13, 175-180.
30. Abad A, Agulló C, Arnó M, Domingo LR, Zaragozá RJ. (1989) Erythrophleum alkaloids. Synthesis of (-)-4-epi-cassamine. Journal of the Chemical Society, Perkin Transactions I, 1875-1882.
31. Hauth H, Stauffacher D. (1971) Synthese und auftrennung von racemischen, isomeren desoxo-demethylcassain-derivaten. Helvetica Chimica Acta, 54, 1278-1289.
32. Hauth H, Stauffacher D. (1972) Synthese von racemischen, isomeren desoxo-4, 14-dide- methyl-cassain-derivaten. Helvetica Chimica Acta, 55, 1532-1544.
33. Clarke RL, Daum SJ. (1970) Cassaine analogs. VI. Resolution of (±)-7-deoxy-16,17,18,20- tetra-norcassaic acid and biological activity of derived esters. Journal of Medicinal Chemistry, 13, 320-322.
34. Munari SD, Barassi P, Cerri A, Fedrizzi G, Gobbini M, Mabilia M, Melloni P. (1998) A new approach to the design of novel inhibitors of Na+, K+-ATPase: 17α-Substituted seco-D 5β-androstane as cassaine analogues. Journal of Medicinal Chemistry, 41, 3033-3040.
35. Gobbini M, Barassi P, Cerri A, Munari SD, Fedrizzi G, Santagostino M, Schiavone A, Torri M, Melloni P. (2001) 17α-O- (Aminoalkyl) oxime derivatives of 3β, 14β-dihydroxy-5β- androstane and 3β-hydroxy-14-oxoseco-D-5β-androstane as inhibitors of Na+, K+-ATPase at the digitalis receptor. Journal of Medicinal Chemistry, 44, 3821-3830.
36. Baker RW, Knox JR, Skelton BW, White AH. (1991) Structural parallels between the cardiotonic steroids and the Erythrophleum alkaloids-II. Synthesis and Na+, K+-ATPase inhibitory activity of novel Erythrophleum alkaloid analogues. Tetrahedron, 47, 7965-7980.
37. Daum SJ, Riano MM, Shaw PE, Clarke RL. (1967) Cassaine analogs. III. Synthesis of dl- 15,16,17,20-tetranorcassaine. Journal of Organic Chemistry, 32, 1435-1441.
38. Clarke RL, Daum SJ, Shaw PE, Brown TG, Jr, Groblewski GE, O'Connor WV. (1967) Cassaine analogs. II. 7-Deoxy basic esters. Journal of Medicinal Chemistry, 10, 582-593.
39. Tobin T, Akera T, Brody TM, Taneja HR. (1976) Studies on the stable inhibition of Na+/K+-ATPase by cassaine. European Journal of Pharmacology, 35, 59-68.
40. Akera T, Ng YC, Hadley R, Katano Y, Brody TM. (1986) High affinity and low affinity ouabain binding sites in the rat heart. European Journal of Pharmacology, 132, 137-146.
41. Melero CP, Medarde M, Feliciano AS. (2000) A short review on cardiotonic steroids and their aminoguanidine analogues. Molecules, 5, 51-81.
42. Repke KRH, Megges R, Weiland J. (1997) Differentiation between various types of inotropes through discovery of differences in their ability to detect isoforms of Na+, K+-ATPase. Journal of Enzyme Inhibition, 12, 53-58.
43. Zlegler MS, Herbst RM. (1951) Alicyclic carboxylic acids. The dialkylaminoethyl carboxylic acids. Journal of Organic Chemistry, 16, 920-929.
44. Cronlund A. (1976) Metabolism of cassaidine in the guinea pig. Acta Pharmaceutica Suecica, 13, 43-50.
45. Tobin T, Akera T, Brody SL, Ku D, Brody TM. (1975) Cassaine: Mechanism of inhibition of Na+/K+-ATPase and relationship of this inhibition to cardiotonic actions. European Journal of Pharmacology, 32, 133-145.
46. Hoeltje HD, Anzali S. (1992) Molecular modeling studies on the digitalis binding site of the sodium, potassium-ATPase. Pharmazie, 47, 691-697.
47. Repke KRH, Weiland J, Menke KH. (1991) Chemical models for the chemical nature of endogenous digitalis. Journal of Enzyme Inhibition, 5, 25-32.
48. Bonting SL, Hawkins NM, Canady MR. (1964) Studies of sodium-potassium activated adenosine triphosphatase: VII -inhibition by erythrophleum alkaloids. Biochemical Pharmacology, 13, 13-22.
49. Peters T, Raben RH, Wassermann O. (1974) Evidence for a dissociation between positive inotropic effect and inhibition of the Na+-K+-ATPase by ouabain, cassaine and their alkylating derivatives. European Journal of Pharmacology, 26, 166-174.
50. Brown HD. (1966) Azasteroids and heart adenosine triphosphatase. Biochemical Pharmacology, 15, 2007-2011.
51. Bakkeren JAJM, Bonting SL. (1968) Studies on (Na+-K+)-activated ATPase. XX. Properties of (Na+-K+)-activated ATPase in rat liver. Biochimica et Biophysica Acta (BBA) - Biomembranes, 150, 460-466.
52. Repke K, Est M, Portius HJ. (1965) Über die ursache der speciesunterschiede in der digitalisempfindlichkeit. Biochemical Pharmacology, 14, 1785-1802.
53. Akera T, Ng YC, Shieh IS, Bero E, Brody TM, Braselton WE. (1985) Effects of K+ on the interaction between cardiac glycosides and Na, K-ATPase. European Journal of Pharmacology, 111, 147-157.
54. Huang M, Shimizu H, Daly JW. (1972) Accumulation of cyclic adenosine monophosphate in incubated slices of brain tissue. 2. Effects of depolarizing agents, membrane stabilizers, phosphodiesterase inhibitors, and adenosine analogs. Journal of Medicinal Chemistry, 15, 462-466.
55. Hanke DW, Nelson ME, Baskin SI. (1991) Cardiotonic drugs inhibit purified mammalian acetylcholinesterase. Journal of Applied Toxicology, 11, 119-124.
56. Gupta RS, Chopra A, Trott AB. (1989) Development of a specific assay for cardiac glycoside-like compounds based on crossresistance of human cell mutants. Biochemical Pharmacology, 38, 2159-2168.
57. Gupta RS, Chopra A, Stetsko DK. (1986) Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis). Journal of Cellular Physiology, 127, 197-206.
58. Gupta RS. (1981) Mutants of Hela cells resistant to ouabain and cassaine: genetic evidence for the common site of action of cardiac glycosides and Erythrophleum alkaloids. Biochemical Pharmacology, 30, 3039-3044.
59. Rosenberg HM. (1975) Variant HeLa cells selected for their resistance to ouabain. Journal of Cellular Physiology, 85, 135-142.
60. Gupta RS, Chopra A. (1985) Cross-resistance and biochemical studies with two classes of Hela cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide Sc4453. The Journal of Biological Chemistry, 260, 6843-6850.